Hereditary Gastric Cancer: Single-Gene or Multigene Panel Testing? A Mono-Institutional Experience.

BRCA1 BRCA2 CDH1 MSH2 gastric cancer hereditary diffuse gastric cancer syndrome homologous recombination DNA repair genes multigene panel testing

Journal

Genes
ISSN: 2073-4425
Titre abrégé: Genes (Basel)
Pays: Switzerland
ID NLM: 101551097

Informations de publication

Date de publication:
13 05 2023
Historique:
received: 14 04 2023
revised: 05 05 2023
accepted: 11 05 2023
medline: 29 5 2023
pubmed: 27 5 2023
entrez: 27 5 2023
Statut: epublish

Résumé

Gastric cancer (GC) has long been a 'Cinderella' among hereditary cancers. Until recently, single-gene testing (SGT) was the only approach to identify high-risk individuals. With the spread of multigene panel testing (MGPT), a debate arose on the involvement of other genes, particularly those pertaining to homologous recombination (HR) repair. We report our mono-institutional experience in genetic counseling and SGT for 54 GC patients, with the detection of nine pathogenic variants (PVs) (9/54:16.7%). Seven out of fifty (14%) patients who underwent SGT for unknown mutations were carriers of a PV in

Identifiants

pubmed: 37239438
pii: genes14051077
doi: 10.3390/genes14051077
pmc: PMC10218517
pii:
doi:

Substances chimiques

MutS Homolog 2 Protein EC 3.6.1.3

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Front Genet. 2022 Nov 16;13:1026871
pubmed: 36468004
J Med Genet. 2023 Jan 10;:
pubmed: 36627197
Nat Commun. 2015 Dec 22;6:10086
pubmed: 26689913
Best Pract Res Clin Gastroenterol. 2022 Jun-Aug;58-59:101800
pubmed: 35988963
Genet Med. 2020 Jan;22(1):15-25
pubmed: 31337882
Clin Exp Gastroenterol. 2018 Dec 03;11:447-459
pubmed: 30584346
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Ann Surg Oncol. 2017 Nov;24(12):3683-3691
pubmed: 28895113
Am J Hum Genet. 2016 May 5;98(5):830-842
pubmed: 27087319
J Clin Oncol. 2017 Jul 1;35(19):2165-2172
pubmed: 28489507
Histopathology. 2021 Jan;78(1):125-147
pubmed: 33382491
EClinicalMedicine. 2022 Apr 21;47:101404
pubmed: 35497064
Lancet Oncol. 2020 Aug;21(8):e386-e397
pubmed: 32758476
Hum Mutat. 2008 Nov;29(11):1282-91
pubmed: 18951446
Acta Pathol Microbiol Scand. 1965;64:31-49
pubmed: 14320675
Gastroenterology. 2017 Apr;152(5):983-986.e6
pubmed: 28024868
J Med Genet. 1999 Dec;36(12):873-80
pubmed: 10593993
J Natl Compr Canc Netw. 2020 Apr;18(4):380-391
pubmed: 32259785
Chin J Cancer Res. 2020 Aug;32(4):508-515
pubmed: 32963463
J Med Genet. 2021 Jan;58(1):1-11
pubmed: 32066632
Gut. 2012 May;61(5):774-9
pubmed: 21813476
JCO Precis Oncol. 2017 Nov;1:1-12
pubmed: 35172483
J Clin Oncol. 2022 May 10;40(14):1529-1541
pubmed: 35077220
Br J Cancer. 2018 Apr;118(7):938-946
pubmed: 29527010
N Engl J Med. 2023 Mar 30;388(13):1181-1190
pubmed: 36988593
Eur J Med Genet. 2022 Jan;65(1):104401
pubmed: 34871783
Lancet Oncol. 2015 Feb;16(2):e60-70
pubmed: 25638682
Dig Dis Sci. 2022 Nov;67(11):5107-5115
pubmed: 35122589

Auteurs

Mariarosaria Calvello (M)

Division of Cancer Prevention and Genetics, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.

Monica Marabelli (M)

Division of Cancer Prevention and Genetics, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.

Sara Gandini (S)

Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.

Elena Marino (E)

Clinic Unit of Oncogenomics, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.

Loris Bernard (L)

Clinic Unit of Oncogenomics, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.

Matteo Dal Molin (M)

Clinic Unit of Oncogenomics, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.

Giulia Di Cola (G)

Clinic Unit of Oncogenomics, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.

Cristina Zanzottera (C)

Division of Cancer Prevention and Genetics, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.

Giovanni Corso (G)

Division of Breast Surgery, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.
Department of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy.
European Cancer Prevention Organization (ECP), 20122 Milan, Italy.

Nicola Fazio (N)

Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.

Lorenzo Gervaso (L)

Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.
Molecular Medicine Program, University of Pavia, 27100 Pavia, Italy.

Uberto Fumagalli Romario (U)

Digestive Surgery, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.

Massimo Barberis (M)

Clinic Unit of Oncogenomics, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.

Aliana Guerrieri-Gonzaga (A)

Division of Cancer Prevention and Genetics, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.

Lucio Bertario (L)

Division of Cancer Prevention and Genetics, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.

Davide Serrano (D)

Division of Cancer Prevention and Genetics, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.

Bernardo Bonanni (B)

Division of Cancer Prevention and Genetics, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH